MultiPlan (MPLN)
(Real Time Quote from BATS)
$0.25 USD
0.00 (-0.08%)
Updated Aug 28, 2024 11:04 AM ET
3-Hold of 5 3
A Value D Growth D Momentum B VGM
Price, Consensus and EPS Surprise
MPLN 0.25 0.00(-0.08%)
Will MPLN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MPLN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MPLN
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar?
MPLN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MPLN
Analysts Conflicted on These Healthcare Names: Nyxoah (NYXH), MultiPlan (MPLN) and Beam Therapeutics (BEAM)
MultiPlan price target lowered by $1 at Piper Sandler, here's why
MultiPlan Earns 2024 Great Place to Work Certification?
Grant of Awards to New MultiPlan Executive Officers under NYSE Listing Rules
MultiPlan Corporation (MPLN) Q2 2024 Earnings Call Transcript